Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05794815
NA
Modulation of Gut Microbiota by Probiotic in Children With Respiratory Symptoms
Sponsor: Min-Tze LIONG
View on ClinicalTrials.gov
Summary
This project aims to study the benefits of probiotics namely Bifidobacterium infantis YLGB-1496 in modulating gut microbiota of children with respiratory symptoms, among pre-school children in Malaysia aged \>12 months old, \<7 years old.
Key Details
Gender
All
Age Range
12 Months - 7 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2023-05-01
Completion Date
2026-05-01
Last Updated
2023-08-22
Healthy Volunteers
No
Interventions
DIETARY_SUPPLEMENT
Probiotic
Bifidobacterium infantis YLGB-1496 at 1x10 log CFU/day for 12 weeks
DIETARY_SUPPLEMENT
Placebo
Intervention consists of daily administration of 2g of maltodextrin, administered daily for 12-weeks)
Locations (1)
UKM Medical Centre
Cheras, Kuala Lumpur, Malaysia